NIDA Notes Articles: Treatment Research

Sort by:
Date
Title

Stress Receptor Mediates Lifelong Consequences of Early Trauma

November 2012

NIDA-supported research suggests that glucocorticoid receptor levels during early brain development affect the hard wiring of neural circuits that shape an individual’s basic emotional makeup. In mice, overexpression of the glucocorticoid gene in the first weeks after birth increased anxiety and response to cocaine in adulthood. These findings may help researchers understand the genetic background and the developmental trajectory of addiction.

Dr. Charles O’Brien Receives the James B. Isaacson Award for Lifetime Achievement

November 2012

NIDA researcher Dr. Charles O’Brien recently received the James B. Isaacson Award for a lifetime of research on the biological basis of alcoholism.

Q&A: Dr. David Thomas

November 2012

NIDA Program Officer Dr. David Thomas speaks about the intertwined problems of pain and prescription opioid abuse, as well as the research supported by NIDA and the National Institutes of Health to address these problems.

Animal Research Advances Effort to Develop Vaccines Against Cocaine, Heroin Abuse

September 2012

New vaccines that aim to promote recovery from cocaine and heroin abuse showed promise in animal testing. Both vaccines induced rats’ immune system to produce high titers of antibodies that inhibit the target drug from reaching the brain. The rats’ behaviors when given access to the target drug indicated that the vaccines reduced the reinforcing effects that, in recovering people, can cause lapses to turn into relapses.

Few Teens With Prescription Opioid Use Disorders Receive Treatment

July 2012

Fewer than 12 percent of adolescents who meet diagnostic criteria for prescription opioid abuse or dependence receive any treatment, according to an analysis of data from the 2005 to 2008 National Survey on Drug Use and Health. The most common reason the adolescents gave for not receiving treatment was their lack of perceived need for it.

Intervention Boosts Treatment Participation, Abstinence Among Depressed Women

July 2012
Intensive case management was more effective in increasing treatment engagement and reducing alcohol consumption among depressed participants than among those who were not depressed, according to a followup analysis of a substance abuse treatment study involving women on welfare.

Program Reduces Recidivism Among Men With Co-occurring Disorders

July 2012
A modified therapeutic community program designed by NIDA-supported researchers helped Colorado offenders with co-occurring substance use and mental health disorders re-enter their communities and avoid recidivism after release from prison.

The Present and Promise of mHealth

July 2012
NIDA researchers have developed a computer program that motivates and encourages treatment-seeking when an individual is in a primary care physician’s waiting room. Users of the program, called Video Doctor, enter information on a portable device and receive feedback about health risks related to their drug abuse, along with advice, immediately prior to seeing their physician.

Dr. David Jentsch Receives the 2011 Waletzky Memorial Award

July 2012
Dr. J. David Jentsch is the recipient of the 2011 Jacob P. Waletzky Memorial Award for Innovative Research in Drug Addiction and Alcoholism. Dr. Jentsch and colleagues at the University of California, Los Angeles, are studying genetic and neurochemical factors that influence individual differences in inhibitory control.

Well-Known Mechanism Underlies Benzodiazepines' Addictive Properties

April 2012
New research establishes that benzodiazepines cause addiction in a way similar to that of opioids, cannabinoids, and the club drug GHB. The discovery opens the door to designing new benzodiazepines that counteract anxiety but are not addictive.

Pages

Dates

Menu

Stress Receptor Mediates Lifelong Consequences of Early Trauma

Dr. Charles O’Brien Receives the James B. Isaacson Award for Lifetime Achievement

Q&A: Dr. David Thomas

Animal Research Advances Effort to Develop Vaccines Against Cocaine, Heroin Abuse

Few Teens With Prescription Opioid Use Disorders Receive Treatment

Intervention Boosts Treatment Participation, Abstinence Among Depressed Women

Program Reduces Recidivism Among Men With Co-occurring Disorders

The Present and Promise of mHealth

Dr. David Jentsch Receives the 2011 Waletzky Memorial Award

Well-Known Mechanism Underlies Benzodiazepines' Addictive Properties

Pages

Sections

Dates

2013

2012

2011

2010

2009

2008

2007

2006

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics